Pharmacokinetics of the new cephalosporins.
D002433:Cefaclor / Q000378:metabolism; D002434:Cefadroxil; D002435:Cefamandole / Q000031:analogs & derivatives / Q000378:metabolism; D002437:Cefazolin / Q000031:analogs & derivatives / Q000378:metabolism; D015311:Cefmetazole; D015790:Cefonicid; D002438:Cefoperazone; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000378:metabolism; D015310:Cefotiam; D002441:Cefsulodin; D015296:Ceftizoxime; D002506:Cephalexin / Q000031:analogs & derivatives / Q000378:metabolism; D002511:Cephalosporins / Q000378:metabolism*; D002513:Cephamycins / Q000378:metabolism; D002515:Cephradine / Q000031:analogs & derivatives / Q000378:metabolism; D006801:Humans; D007408:Intestinal Absorption; D007700:Kinetics; D009070:Moxalactam; D014018:Tissue Distribution
D002511:Cephalosporins; D002513:Cephamycins; D002434:Cefadroxil; D015311:Cefmetazole; D002435:Cefamandole; D015790:Cefonicid; D002433:Cefaclor; D002438:Cefoperazone; C021341:cefazedone; C012653:ceforanide; D015310:Cefotiam; C012671:cefroxadine; D015296:Ceftizoxime; D002515:Cephradine; D002437:Cefazolin; D002439:Cefotaxime; D002506:Cephalexin; D002441:Cefsulodin; D009070:Moxalactam